Formal Policies and Special Informed Consent Are Associated with Higher Provider Utilization of CDC High-Risk Donor Organs
Open Access
- 1 March 2009
- journal article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 9 (3), 629-635
- https://doi.org/10.1111/j.1600-6143.2008.02523.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Viral Nucleic Acid Testing (NAT) and OPO-Level Disposition of High-Risk Donor OrgansAmerican Journal of Transplantation, 2009
- The high-risk donor: viral infections in solid organ transplantationCurrent Opinion in Organ Transplantation, 2008
- Informing Candidates for Solid-Organ Transplantation about Donor Risk FactorsNew England Journal of Medicine, 2008
- Enhancing Transplant Safety: A New Era in the Microbiologic Evaluation of Organ Donors?American Journal of Transplantation, 2007
- The Risk of HIV, HBV, HCV and HTLV Infection Among Musculoskeletal Tissue Donors in AustraliaAmerican Journal of Transplantation, 2007
- Assessing the impact of HBV NAT on window period reduction and residual riskJournal of Clinical Virology, 2006
- A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donorsTransfusion, 2005
- Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?Transfusion Clinique et Biologique, 2004
- Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti‐HBc: implications for transfusion transmission and donor screeningTransfusion, 2003
- Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donorsTransfusion, 1995